GNC Holdings (GNC) to Coninue Selling Stimulant DMAA - CNBC
Tweet
Share
E-mailGet Alerts GNC Hot Sheet
Join SI Premium – FREE
GNC Holdings (NYSE: GNC) is seeing some activity on headlines from CNBC that it will continue to sell products containing DMAA. It was reported earlier that the U.S. FDA sent warnings letters to 10 companies who produce DMAA and products from the stimulant for not properly following safety protocol.
For more on the report, click here.
GNC is now about 5.4 percent lower, off of intraday lows.
For more on the report, click here.
GNC is now about 5.4 percent lower, off of intraday lows.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sellas presents preclinical SLS009 pancreatic cancer data at AACR
- Verastem data on ovarian cancer drug combo set for IGCS 2026
- Imunon presents Phase 3 ovarian cancer trial data at R&D Day
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
